دورية أكاديمية
High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study
العنوان: | High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study |
---|---|
المؤلفون: | Rongyi, ChenAff1, Aff2, Xiaojuan, DaiAff1, Aff2, Jinghua, WangAff1, Aff2, Lingying, MaAff1, Aff2, Xiaomin, DaiAff1, Aff2, Lili, MaAff1, Aff2, Huiyong, ChenAff1, Aff2, IDs13075023031067_cor7, Lindi, JiangAff1, Aff2, IDs13075023031067_cor8, Ying, SunAff1, Aff2, IDs13075023031067_cor9 |
المصدر: | Arthritis Research & Therapy. 25(1) |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 14786362 |
---|---|
DOI: | 10.1186/s13075-023-03106-7 |